El cribratge del cancer de mama a Catalunya, quina estrategia es preferible?

PMM (Petra) Beemsterboer; PG (Peter) Warmerdam; Rob Boer; JM Borras; V Moreno; P Viladiu; Harry de Koning

El cribratge del cancer de mama a Catalunya, quina estrategia es preferible?

PMM (Petra) Beemsterboer, PG (Peter) Warmerdam, Rob Boer, JM Borras, V Moreno, P Viladiu, Harry de Koning

Public Health

Research output: Chapter/Conference proceeding › Chapter › Academic

Original language	Undefined/Unknown
Title of host publication	El cribratge del cancer de mama a Catalunya: Cost-efectivitat, impacte assistencial i cost del tractament del cancer de mama
Editors	P. Viladiu, A. Granados
Place of Publication	Barcelona
Pages	21-33
Number of pages	13
Publication status	Published - 1997

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@inbook{bf1c18ee52954e349d793ae1a84951d2,

title = "El cribratge del cancer de mama a Catalunya, quina estrategia es preferible?",

author = "Beemsterboer, {PMM (Petra)} and Warmerdam, {PG (Peter)} and Rob Boer and JM Borras and V Moreno and P Viladiu and {de Koning}, Harry",

year = "1997",

language = "Undefined/Unknown",

pages = "21--33",

editor = "P. Viladiu and A. Granados",

booktitle = "El cribratge del cancer de mama a Catalunya: Cost-efectivitat, impacte assistencial i cost del tractament del cancer de mama",

}

El cribratge del cancer de mama a Catalunya, quina estrategia es preferible? / Beemsterboer, PMM (Petra); Warmerdam, PG (Peter); Boer, Rob et al.
El cribratge del cancer de mama a Catalunya: Cost-efectivitat, impacte assistencial i cost del tractament del cancer de mama. ed. / P. Viladiu; A. Granados. Barcelona, 1997. p. 21-33.